Filter

Refine by Subjects

Refine by Access

Refine by Type

Refine by Date

—
  • Print
  • Save

Search Results

You are looking at 41 - 50 of 316 items for :

  • Author or Editor: Elham Amiri x
  • Drug Information x
  • Refine by Access: All content x
Clear All Modify Search
Restricted access

Phenoxybenzamine Hydrochloride Solution 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Procainamide Hydrochloride Suspension 50 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Atenolol Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Propylthiouracil Suspension 5 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Propylthiouracil Suspension 5 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Pyrazinamide Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Pyrazinamide Suspension 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Pyrazinamide Syrup 100 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Pyridoxine Hydrochloride Suspension 50 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Pyrimethamine Suspension 2 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022